Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
01 1Olpha As
02 42care4 ApS
03 1Accord Healthcare Ireland Ltd
04 2Adamed Sp. z.o.o.
05 2Alter Laboratories Sa
06 1Aurovitas Spain, Sau
07 3BOEHRINGER INGELHEIM INT.GMBH
08 5Boehringer Ingelheim (Switzerland) Gmbh
09 5Boehringer Ingelheim Int. Gmbh
10 10Boehringer Ingelheim International GmbH
11 20Boehringer Ingelheim International Gmbh
12 2Cinfa Laboratories Sa
13 3Clonmel Healthcare Limited
14 1Combix Laboratories Slu
15 3Innovis Pharma Sa
16 1Intas Third Party Sales 2005 Sl
17 1Kern Pharma Sl
18 1Krka D.D. Novo Mesto
19 1Krka Dd Novo Mesto
20 1Krka, D.D., Novo Mesto
21 3Medochemie Limited
22 2Novalie Pharma Bv
23 4PharOS – Pharmaceutical Oriented Services Limited
24 5PharmaPath S.A.
25 8Pharmapath Sa
26 2Pharos Pharmaceutical Oriented Services Ltd.
27 1Sandoz A/S
28 3Sandoz Pharmaceuticals D.D.
29 3Sandoz Pharmaceuticals Sa
30 4Sandoz Pharmaceuticals d.d.
31 3Stada Arzneimittel Ag
32 1Stada Pharmaceuticals Ag
33 3Stada Sl Laboratory
34 2Tarbis Farma Sl
35 4Viatris Limited
36 1Zentiva K.S.
01 5Empagliflozin; Linagliptin
02 40Linagliptin
03 10Linagliptin; Metforminhydroklorid
04 4Linagliptin; Empagliflozin
05 1Linagliptin; Metformin
06 26Linagliptin; Metformin Hydrochloride
07 22Metformin Hydrochloride; Linagliptin
08 9Metformin; Linagliptin
01 98Film Coated Tablet
02 14Film-Coated Tablet
03 1Linagliptin 5Mg 28 Combined Oral Use
04 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
05 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
06 2Blank
01 21Denmark
02 14Estonia
03 3Italy
04 19Malta
05 14Norway
06 2Poland
07 39Spain
08 5Switzerland
01 1Abbreviation "Sandoz"
02 2Autnami
03 1Donumid
04 2Gentadueto
05 4Glymetia
06 8Glyxambi
07 1Glyxambi
08 2Ilinpru
09 26Jentadueto
10 3Jentadueto mg
11 2Liglifev
12 1Linagliptin Accord
13 1Linagliptin Aurovitas
14 1Linagliptin Combix
15 1Linagliptin Intas
16 1Linagliptin Kern Pharma
17 1Linagliptin Krka
18 1Linagliptin Medochemie5
19 1Linagliptin Medochemistry
20 1Linagliptin Olpha
21 1Linagliptin Pharos
22 2Linagliptin Sandoz
23 1Linagliptin Viatris
24 1Linagliptin "Krka"
25 1Linagliptin "Stada"
26 1Linagliptin "Viatris"
27 1Linagliptin “Pharmapathâ€
28 2Linagliptin/Metformin Cinfa
29 3Linagliptin/Metformin Clonmel
30 3Linagliptin/Metformin Hcl Pharos
31 2Linagliptin/Metformin Pharos
32 3Linagliptin/Metformin Sandoz
33 3Linagliptin/Metformin Stada
34 2Linagliptin/Metformin Tarbis
35 1Linagliptina Alter
36 1Linagliptina Medochemie
37 1Linagliptina Pharmapath
38 1Linagliptina Stada
39 2Linagliptina/Metformina Sandoz
40 2Linagliptine/Metformin Stada
41 2Linathan
42 1Lynxaram
43 4Meglithan
44 2Nagilma
45 1Neloviren
46 1Nezodia
47 1Sansik
48 1Tingapla
49 7Trajenta
50 2Blank
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Linagliptin Olpha
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 24-11-2025
Application Number : 90773
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Not Marketed
Registration Country : Norway
Linagliptin; Metforminhydroklorid
Brand Name : Jentadueto
Dosage Form : Film Coated Tablet
Dosage Strength : 2.5mg; 1000mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Not Marketed
Registration Country : Norway
Linagliptin; Metforminhydroklorid
Brand Name : Jentadueto
Dosage Form : Film Coated Tablet
Dosage Strength : 2.5mg; 1000mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Not Marketed
Registration Country : Norway
Linagliptin; Metforminhydroklorid
Brand Name : Jentadueto
Dosage Form : Film Coated Tablet
Dosage Strength : 2.5mg; 850mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Not Marketed
Registration Country : Norway
Linagliptin; Metforminhydroklorid
Brand Name : Jentadueto
Dosage Form : Film Coated Tablet
Dosage Strength : 2.5mg; 850mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Not Marketed
Registration Country : Norway
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Linagliptin Accord
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-02-22
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Regulatory Info : Generic
Registration Country : Poland
Brand Name :
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Poland
Regulatory Info : Generic
Registration Country : Poland
Brand Name :
Dosage Form :
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Poland
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Linagliptina Alter
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 16-04-2025
Application Number : 90288
Regulatory Info : Authorized
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Donumid
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 30-04-2025
Application Number : 90300
Regulatory Info : Authorized
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
